XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.2

EARNINGS (LOSS) PER SHARE (Tables)

6 Months Ended

Jun. 30, 2025

Earnings Per Share [Abstract]

SCHEDULE OF BASIC AND DILUTED EARNINGS (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted earnings (loss) per share:

SCHEDULE OF BASIC AND DILUTED EARNINGS (LOSS) PER SHARE 

		2025				2024				2025				2024
		Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
Numerator:
Net loss attributable to LifeMD, Inc. common stockholders - basic		$	(2,851,436	)		$	(7,652,202	)		$	(2,243,195	)		$	(15,197,120	)
Adjustment			-				-				-				-
Net loss attributable to LifeMD, Inc. common stockholders - diluted		$	(2,851,436	)		$	(7,652,202	)		$	(2,243,195	)		$	(15,197,120	)
Denominator:
Weighted average number of common shares outstanding - basic			44,401,531				41,296,042				43,772,151				40,269,139
Adjustment for the potential dilutive common shares			-				-				-				-
Weighted average number of common shares outstanding - diluted			44,401,531				41,296,042				43,772,151				40,269,139
Basic loss per share attributable to LifeMD, Inc. common stockholders		$	(0.06	)		$	(0.19	)		$	(0.05	)		$	(0.38	)
Diluted loss per share attributable to LifeMD, Inc. common stockholders		$	(0.06	)		$	(0.19	)		$	(0.05	)		$	(0.38	)

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table discloses the securities that were not included in the computation of diluted net earnings (loss) per share as their inclusion would have been anti-dilutive:

 SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

		2025				2024				2025				2024
		Three Months Ended June 30,								Six Months Ended June 30,
		2025				2024				2025				2024
RSUs and RSAs			1,933,014				2,279,750				1,582,467				2,296,125
Stock options			437,544				1,527,000				424,941				1,843,375
Warrants			1,024,809				1,743,730				971,327				2,068,419
Convertible long-term debt			671,141				671,141				671,141				671,141
Total			4,066,508				6,221,621				3,649,876				6,879,060

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration